
The $450 Million Bet on Consumer Diagnostics
A massive new capital injection proves that venture capital is bypassing traditional doctors to sell health tracking directly to anxious consumers.
Discover the newest research about AI innovations in 🩺 Preventive Medicine.

A massive new capital injection proves that venture capital is bypassing traditional doctors to sell health tracking directly to anxious consumers.

An ambitious clinical trial across Australasia is about to test whether machine learning can make split-second decisions to save critically ill patients.

The sudden collapse of a major heart failure trial exposes a quiet failure point in how regulators fast-track medical technology.

A quiet regulatory truce reveals exactly how far consumer wearables can push into clinical territory without triggering a federal crackdown.

NHS digital investment faces challenges due to delivery issues, not ambition. Effective collaboration and support are essential for success. 📊💻

Phthalates linked to increased stroke risk; moderate coffee consumption may reduce this risk. ☕️🧠

AI model improves CT scan analysis, aiding in faster disease diagnosis and prediction. 🩻🤖
AI predicts hip replacement surgery outcomes, aiding patient care. In 2024, 200,000 surgeries performed in Germany. 🦴🤖

AI-driven EcoRxAgent reduces prescription costs by 14.40% to 40.14% while ensuring therapeutic efficacy. 💊🤖

AI enhances personalized treatment for eating disorders, analyzing 35 participants’ EMA data over 14 weeks. 📊🤖